NO20021949L - Nye hormonpreparater og anvendelse av dem - Google Patents

Nye hormonpreparater og anvendelse av dem

Info

Publication number
NO20021949L
NO20021949L NO20021949A NO20021949A NO20021949L NO 20021949 L NO20021949 L NO 20021949L NO 20021949 A NO20021949 A NO 20021949A NO 20021949 A NO20021949 A NO 20021949A NO 20021949 L NO20021949 L NO 20021949L
Authority
NO
Norway
Prior art keywords
hormone preparations
new hormone
new
preparations
hormone
Prior art date
Application number
NO20021949A
Other languages
English (en)
Other versions
NO20021949D0 (no
NO327973B1 (no
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO20021949D0 publication Critical patent/NO20021949D0/no
Publication of NO20021949L publication Critical patent/NO20021949L/no
Publication of NO327973B1 publication Critical patent/NO327973B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20021949A 1999-10-25 2002-04-25 Anvendelse av en kombinert ostroprogestativ forbindelse for fremstilling av et medikament for korreksjon av ostrogenforstyrrelser hos kvinner samt forebyggelse av osteoporose og kardiovaskulaere sykdommer hos kvinner i overgangsalder NO327973B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002588 WO2001030356A1 (fr) 1999-10-25 1999-10-25 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
PCT/FR2000/002939 WO2001030357A1 (fr) 1999-10-25 2000-10-24 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Publications (3)

Publication Number Publication Date
NO20021949D0 NO20021949D0 (no) 2002-04-25
NO20021949L true NO20021949L (no) 2002-04-25
NO327973B1 NO327973B1 (no) 2009-11-02

Family

ID=9542727

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021949A NO327973B1 (no) 1999-10-25 2002-04-25 Anvendelse av en kombinert ostroprogestativ forbindelse for fremstilling av et medikament for korreksjon av ostrogenforstyrrelser hos kvinner samt forebyggelse av osteoporose og kardiovaskulaere sykdommer hos kvinner i overgangsalder

Country Status (27)

Country Link
US (2) US8168619B1 (no)
EP (1) EP1227814B1 (no)
JP (1) JP5036943B2 (no)
KR (1) KR100623788B1 (no)
CN (1) CN100553637C (no)
AP (1) AP1625A (no)
AT (1) ATE286400T1 (no)
AU (1) AU777704B2 (no)
BR (1) BRPI0014979B8 (no)
CA (1) CA2389025C (no)
CZ (1) CZ303248B6 (no)
DE (1) DE60017281T2 (no)
DK (1) DK1227814T3 (no)
ES (1) ES2235967T3 (no)
HK (1) HK1050472B (no)
HU (1) HU229382B1 (no)
IL (2) IL148953A0 (no)
MX (1) MXPA02004084A (no)
NO (1) NO327973B1 (no)
NZ (1) NZ518145A (no)
OA (1) OA12072A (no)
PL (1) PL199848B1 (no)
PT (1) PT1227814E (no)
RU (1) RU2261106C2 (no)
SI (1) SI1227814T1 (no)
WO (2) WO2001030356A1 (no)
ZA (1) ZA200203398B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
DE60217324T2 (de) 2001-05-18 2007-04-26 Pantarhei Bioscience B.V. Pharmazeutische zusammensetzung für die hormonersatztherapie
ES2337129T3 (es) 2001-05-23 2010-04-21 Pantarhei Bioscience B.V. Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
DK1390042T3 (da) 2001-05-23 2008-03-31 Pantarhei Bioscience Bv System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse
DE60216630T2 (de) * 2001-11-15 2007-09-20 Pantarhei Bioscience B.V. Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
CA2489271C (en) 2002-06-11 2011-12-06 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
AU2003274941A1 (en) 2002-06-11 2003-12-22 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
JP2005535624A (ja) * 2002-06-25 2005-11-24 ワイス ホルモン関連症状の治療におけるシクロチオカルバメート誘導体の使用
ES2299730T3 (es) 2002-07-12 2008-06-01 Pantarhei Bioscience B.V. Composicion farmaceutica que comprende derivados de estetrol para el uso en la terapia del cancer.
SI1556058T1 (sl) 2002-10-23 2008-02-29 Pantarhei Bioscience Bv Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
DE602008001783D1 (de) 2007-01-08 2010-08-26 Pantarhei Bioscience Bv Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
CN107007611B (zh) * 2017-06-02 2020-04-14 上海市计划生育科学研究所 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
DE3603644A1 (de) 1986-02-06 1987-08-13 Metabowerke Kg Spannfutter zum einspannen von bohrern oder schlagbohrern
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
FI101601B (fi) 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
FR2695826B1 (fr) 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
EP0843555B1 (en) 1995-08-01 2003-08-27 Isis Pharmaceuticals, Inc. Liposomal oligonucleotide compositions
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5888543A (en) 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
PT1443966E (pt) * 2001-11-15 2007-06-21 Pantarhei Bioscience Bv Método para a prevenção ou tratamento das doenças ginecológicas benignas
PE20081895A1 (es) 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Also Published As

Publication number Publication date
ATE286400T1 (de) 2005-01-15
MXPA02004084A (es) 2003-08-20
OA12072A (fr) 2006-05-04
WO2001030357A1 (fr) 2001-05-03
US20130172300A1 (en) 2013-07-04
JP2003515531A (ja) 2003-05-07
DE60017281T2 (de) 2005-12-08
HK1050472A1 (en) 2003-06-27
NO20021949D0 (no) 2002-04-25
BRPI0014979B1 (pt) 2016-08-02
PT1227814E (pt) 2005-05-31
EP1227814B1 (fr) 2005-01-05
HK1050472B (zh) 2005-07-08
BR0014979A (pt) 2002-11-26
KR100623788B1 (ko) 2006-09-18
IL148953A (en) 2007-06-03
RU2261106C2 (ru) 2005-09-27
AP1625A (en) 2006-07-04
US8168619B1 (en) 2012-05-01
CZ20021427A3 (cs) 2002-08-14
PL199848B1 (pl) 2008-11-28
DE60017281D1 (de) 2005-02-10
SI1227814T1 (en) 2005-06-30
DK1227814T3 (da) 2005-04-11
NO327973B1 (no) 2009-11-02
HUP0203721A2 (hu) 2003-03-28
NZ518145A (en) 2005-01-28
BRPI0014979B8 (pt) 2021-05-25
AU1032601A (en) 2001-05-08
RU2002113652A (ru) 2004-03-27
PL356847A1 (en) 2004-07-12
CN100553637C (zh) 2009-10-28
CA2389025C (fr) 2009-12-08
KR20020057979A (ko) 2002-07-12
ZA200203398B (en) 2003-12-03
CN1382053A (zh) 2002-11-27
HUP0203721A3 (en) 2003-07-28
ES2235967T3 (es) 2005-07-16
HU229382B1 (hu) 2013-11-28
IL148953A0 (en) 2002-11-10
WO2001030356A1 (fr) 2001-05-03
CA2389025A1 (fr) 2001-05-03
CZ303248B6 (cs) 2012-06-20
JP5036943B2 (ja) 2012-09-26
AU777704B2 (en) 2004-10-28
US9084796B2 (en) 2015-07-21
AP2002002475A0 (en) 2002-06-30
EP1227814A1 (fr) 2002-08-07

Similar Documents

Publication Publication Date Title
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
NO20022289D0 (no) Ny anvendelse og nye N-azabisykloamidderivater
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
NO996433L (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20015859L (no) A-<beta>-peptidpreparater og fremgangsmåte for fremstilling av slike
DE60018786D1 (de) Kapselsackring und system bestehend aus ring und dessen einführungsvorrichtung
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
NO20011157L (no) Benzenderivater og farmasöytisk anvendelse derav
DK1173187T3 (da) Kombinationspræparater indeholdende morpholinylanthracycliner og platinderivater
NO20021949L (no) Nye hormonpreparater og anvendelse av dem
IS6420A (is) Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
TR200002099A3 (tr) Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO994659D0 (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO995838D0 (no) Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees